Pillstats
Rx only · Capsule · Oral

Doxycycline

Brands: Oracea · Doxycycline

31 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US74 NDCs
31 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA01AB22
RxCUI (US)3640
US makers31 labelers
Packages237
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 28 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.06$2.12$3.18$4.25Dec 2025Apr 2026Jul 2026
$2.346
Latest avg · Jul 22, 2026
-36%
Since Dec 17, 2025
31
Active US suppliers
36%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

203K406K609K812K2025 Q12025 Q22025 Q32025 Q42026 Q1
615K
Rx · 2026 Q1
15.4M
Units dispensed
-13%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it31 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager52SUPPLYING
Proficient Rx LPunknown33SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown22SUPPLYING
Zydus Lifesciences Limitedunknown22SUPPLYING
REMEDYREPACK INC.repackager16SUPPLYING
Alembic Pharmaceuticals Limitedunknown14SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown12SUPPLYING
Strides Pharma Science Limitedunknown9SUPPLYING
A-S Medication Solutionsunknown6SUPPLYING
Lupin Pharmaceuticals,Inc.unknown6SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown5SUPPLYING
Preferred Pharmaceuticals Inc.unknown5SUPPLYING
Asclemed USA, Inc.unknown4SUPPLYING
Amneal Pharmaceuticals LLCunknown4SUPPLYING
NuCare Pharmaceuticals, Inc.unknown4SUPPLYING

+ 16 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 13, 2022
    RECALLRecall (Class II): Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Distributed by: Sun Pharmaceuticals, NDC 63304-616-50

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.

  • Jan 26, 2022
    RECALLRecall (Class II): Doxycycline Capsules, USP 100 mg, 50 Capsules, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryl…

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — Recalling firm: CARDINAL HEALTHCARE — Nationwide USA

  • Mar 13, 2020
    RECALLRecall (Class II): Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ …

    CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions. — Recalling firm: Sun Pharmaceutical Industries, Inc. — Nationwide in the USA

  • Mar 13, 2020
    RECALLRecall (Class II): Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ …

    CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions. — Recalling firm: Sun Pharmaceutical Industries, Inc. — Nationwide in the USA